Vascular Access Systems Market - Forecasts from 2018 to 2023

The vascular access systems market was valued at US$4.213 billion in 2017 and is projected to expand at a CAGR of 6.20% over the forecast period to reach US$6.044 billion by 2023. Venous or arterial access is obtained through vascular access systems. The procedure involves placing rigid plastic tubes into blood vessels such as the basilic vein and subclavian vein to perform diagnostic tests and treatments such as chemotherapy, intravenous antibiotic treatment, and intravenous feeding. It includes blood sampling, blood transfusion, fluid infusion and central venous pressure readings. The blood is obtained from or delivered to a person’s blood stream over a continuous period through different vascular access devices such as cannulae, catheters, peripherals, and ports. The procedure relieves patients from the continuous stress of needles and offers a painless method to draw blood or provide medication. Rising global prevalence of diseases such as kidney failure, diabetes, and cancer which involve transfer of blood to and from human body is positively impacting the demand for vascular access systems. High infection risk associated with vascular access devices and stringent government approval regulations restrains the growth of vascular access systems market.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Vascular Access System value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the Vascular Access Systems market.

Major industry players profiled as part of the report are Edwards Lifesciences Corporation, C.R. Bard, Inc., BD, and Teleflex Incorporated among others.

Segmentation:

The Vascular Access Systems market has been analyzed through following segments:

By Product:

• Peripherally Inserted Central Catheter (PICC)


• Non-Tunneled Central Catheter


• Tunneled Catheter


• Port Catheter

By Application:

• Intravenous Antibiotic Treatment


• Blood Transfusion


• Long-Term IV Feeding


• Chemotherapy


• Others

By End User:

• Hospitals and Clinics


• Ambulatory Surgical Centers


• Catheterization Labs

By Geography:

• North America


• United States


• Canada


• Mexico


• Others


• South America


• Brazil


• Argentina


• Others


• Europe


• UK


• Germany


• France


• Italy


• Others


• Middle East and Africa


• Israel


• Saudi Arabia


• Israel


• Others


• Asia Pacific


• Japan


• China


• India


• Australia


• Others